TAS 102
An orally bioavailable combination of a nucleoside analog and TPase inhibitor
| Catalog Number | 23932 |
| Research Area | Cancer |
| Molecular Formula | C10H11F3N2O5 • 1/2C9H11ClN4O2 • 1/2HCl |
| CAS# | 2300074-31-9 |
| Purity | ≥98% |
| Inchi | InChI=1S/2C10H11F3N2O5.C9H11ClN4O2.ClH/c2*11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7;10-7-5(12-9(16)13-8(7)15)4-14-3-1-2-6(14)11;/h2*2,5-7,16-17H,1,3H2,(H,14,18,19);11H,1-4H2,(H2,12,13,15,16);1H/t2*5-,6+,7+;;/m00../s1 |
| Inchi Key | KTHXRTQHERFOMN-GIZOTSQLSA-N |
| SMILES | O=C(NC(C(C(F)(F)F)=C1)=O)N1[C@H]2C[C@H](O)[C@@H](CO)O2.O=C(NC(C(C(F)(F)F)=C3)=O)N3[C@H]4C[C@H](O)[C@@H](CO)O4.ClC5=C(CN6CCCC6=N)NC(NC5=O)=O.Cl |
| Size | 25 mg |
| Supplier Page | https://www.caymanchem.com/product/23932 |